New patent for Loxo Oncol drug RETEVMO
Annual Drug Patent Expirations for RETEVMO Retevmo is a drug marketed by Loxo Oncol Eli Lilly and is included in two NDAs. It is available from one supplier. There are five patents protecting this drug. This drug has one hundred and twenty-one patent f…


